An evaluation demonstrating continued efficacy and improved safety and tolerability in 17 patients switched to PEGASYS® after discontinuation from REBETRON™ for the treatment of chronic hepatitis C

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2001-04, Vol.34, p.146-146
Main Authors: Perrillo, R.P., Rothstein, K.D., Alam, I., Thuluvath, P.J., Palmer, M., Pockros, P.J., Pappas, S.C., Doerschuk, B.S., Cantwell, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(01)81406-9